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This is an open-access article distributed under the terms of the Creative Commons 
Attribution-Non Commercial License 4.0 (CCBY-NC) </ext-link>, where it is permissible to 
download, share, remix, transform, and buildup the work provided it is properly cited. The 
work cannot be used commercially without permission from the journal. 
 
Abstract: Musculoskeletal pain is a common cause of work absence and early intervention is 
advocated to prevent the adverse health and economic consequences of longer-term absence. 
This cluster randomised controlled trial investigated the effect of introducing a vocational 
advice service, into primary care to provide occupational support. Six general practices were 
randomised, patients were eligible if they were consulting their general practitioner (GP) with 
musculoskeletal pain, were employed and struggling at work or absent from work <6 months. 
Practices in the intervention arm could refer patients to a vocational advisor embedded within 
the practice providing a case managed stepwise intervention addressing obstacles to working. 
The primary outcome was number of days off work, over 4 months. Participants in the 
intervention arm (n=158) had fewer days work absence compared to the control arm (n=180) 
(mean 9.3 (SD 21·7) versus 14·4 (SD 27·7)) days, Incidence Rate Ratio (IRR) 0·51 (95% 
Confidence Interval 0·26, 0·99), p=0·048). The net societal benefit of the intervention 
compared with best care was £733: £748 gain (work absence) versus £15 loss (health care 
costs). The addition of a vocational advice service to best current primary care for patients 
consulting with musculoskeletal pain led to reduced absence and cost savings for society. If a 
similar early intervention to the one tested in this trial was implemented widely, it could 
potentially reduce days absent over 12 months by 16%, equating to an overall societal cost-
saving of about £500 million (US $6 billion), and requiring an investment of only £10 
million.  
Keywords: Cluster randomised controlled trial; Vocational advice; Occupational advice; 
musculoskeletal pain; Primary care 
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Introduction 
Musculoskeletal pain is one of the most common causes of work absence [1,2]. Across 
Europe almost a quarter of workers will experience pain in their neck, shoulders or upper 
limbs, and an estimated half of the European workforce will experience back pain at some 
point in their lives at a cost of approximately €12 billion overall [3]. The cost of work 
absence attributed to musculoskeletal pain in European Union countries is between 0.5 and 
2.0% of national gross domestic product [3]; pain also has a considerable impact on 
individuals’ earnings and associated costs to the state in benefit payments [4]. In the UK the 
estimated costs in 2003 for GP consultations only as a result of musculoskeletal conditions 
was £1.34 million [5]. The prevalence and incidence of many musculoskeletal conditions 
increase with older age; this, coupled with the rising retirement age, means that the impact of 
musculoskeletal pain on the workforce will rise further [3]. 
 
Remaining active at work, despite pain, has been demonstrated to be beneficial to individuals 
and employers resulting in less sickness absence, less time on modified duties and a reduction 
in pain recurrence [4]. Intervening early when employees report musculoskeletal pain can 
have a significant impact on their ability to remain in work [6,7]. However, the provision of 
independent occupational health services is scarce, and for the majority of working age 
people the first port of call for advice is their General Practitioner (GP) [6]. In the United 
Kingdom the GP is also the gatekeeper to health related benefits through the “Fit Note” 
system whereby absence of greater than seven days is sanctioned. However, many GPs report 
that they feel ill-equipped to manage occupational health issues and have had little or no 
training in the use of Fit Notes [8]. Previous initiatives to address health and work, have been 
aimed primarily at those with longer term absence [9,10]. However, given the evidence that 
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the longer an individual is out of work the less likely it is that they will return, intervening 
before an individual experiences long term absence may be beneficial to both the individual 
and wider society. 
 
Primary care is likely to be the ideal setting in which to offer patients early access to 
appropriate occupational health support, also termed vocational advice, occupational advice, 
and workplace coaching in the literature. Whilst there are guidelines in place to support 
primary care practitioners in providing appropriate advice and support about work, 
implementation of these is variable [11]. Improvement in training and education about 
managing occupational health in primary care should be coupled with provision of services to 
which patients may be referred for advice and assistance about work.  
 
The aim of this cluster randomised controlled trial was to determine whether the addition of a 
vocational advice service to best current primary care can reduce work absence in patients 
consulting their GP for musculoskeletal pain who are either absent from work or struggling to 
remain in work because of their pain. 
 
Methods 
Study design and participants 
The methods are reported in full in the published protocol [12]. The Study of Work and Pain 
(SWAP) was a pragmatic, cluster randomised controlled trial in primary care with two 
parallel arms, an economic evaluation, and linked qualitative interviews (reported separately). 
The unit of randomisation was the general practice with data collected from individual 
participants.  
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Consenting GP practices were randomly assigned to provide either best current primary care 
for managing the impact of musculoskeletal conditions on work or the same best care plus the 
addition of a vocational advice service, located in the practice and staffed by trained 
Vocational Advisors (VAs) who provided occupational advice about working with 
musculoskeletal pain. GP practices were eligible for participation if they were located in the 
National Institute of Health Research Clinical Research Network: West Midlands (NIHR 
CRN: WM), which supports delivery of research within primary care practices in the region. 
Recruitment took place between 2012 and 2014 and participants were followed-up 4 and 12 
months later. Patients were eligible for participation if they: were consulting with 
musculoskeletal pain; aged 18 to 70 years; currently in paid employment; had current 
sickness absence due to musculoskeletal pain of less than 6 months duration (either GP or 
self-certified and either first consultation for a Fit Note or a repeat consultation for a Fit 
Note), or were considered by the GP or Nurse Practitioner (NP) to be struggling with work 
due to musculoskeletal pain. Patients were not eligible for participation if they met any of the 
following criteria (full criteria are reported in the protocol) [12]:  Patients with symptoms 
indicative of possible serious pathology, requiring urgent medical attention; those who have 
long term work absence (greater than 6 months); those with serious mental health problems. 
Eligible patients were identified when they consulted their GP/NP and were introduced to the 
study and given an information pack. The pack contained a letter of invitation, participant 
information sheet, consent form to participate in the research evaluation of the service, self-
completion questionnaire and a pre-paid reply envelope. Eligible patients, not identified 
during the consultation, were later identified by the NIHR CRN: WM through regular 
medical record reviews (see published protocol for full details) [12]. Selection bias was 
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minimised in this cluster trial through identical methods of participant identification, 
invitation and recruitment at both intervention and control practices.  
A trial steering committee and independent Data Monitoring Committee oversaw the trial. 
The National Research Ethics Service West Midlands – Staffordshire in the UK approved the 
protocol (REC reference: 12/WM/0020), and the trial was registered at ISRCTN 52269669. 
 
Randomisation and masking 
GP practices were the unit of randomisation. Practices were matched on registered population 
list size, the matched practices were randomly allocated to the intervention or control arms by 
stratified block randomisation. The randomisation process within the individual blocks was 
computer-generated by the trial statistician. GPs, NPs and VAs could not be blinded to 
allocation. Individual participants were informed that local musculoskeletal services were 
being evaluated and their consent was sought to participate in data collection and medical 
record review. The data were analysed independently by two statisticians one of whom was 
blinded to intervention allocation.  
 
Interventions 
Both intervention and control practices provided best current work-focussed primary care. 
The provision of best current care was supported by providing GPs and NPs with an 
education session lasting one hour. This emphasised four key messages: 1) work is usually 
good for people with musculoskeletal pain, 2) long periods of absence are generally harmful, 
3) musculoskeletal pain can generally be accommodated at work, and 4) planning and 
supporting return-to-work are important aspects of clinical management [4, 13].  
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The intervention practices also hosted a new vocational advice service [12], and GPs and NPs 
could refer patients to the service whether, or not, patients consented to take part in the 
research evaluation. Patients referred to the VA were contacted 5 working days after referral. 
Initial contact was by telephone (step 1), with one or more face-to-face meetings (step 2) and 
contact with employers (step 3) being held subsequently, if required. VAs used the 
“psychosocial flags framework”[13] to assist patients in identifying and overcoming 
obstacles to returning to or remaining in work with their musculoskeletal pain. The VAs 
focussed discussions on three main areas; i) Psychological or behavioural obstacles to 
working e.g. beliefs about pain, illness behaviours (yellow flags) [14]; ii) Work perceptions 
e.g. the beliefs about the physical and social impact of work on health (blue flags) [15]; iii) 
Context factors e.g. objective working conditions and characteristics, and financial impact of 
working status such as job security and benefit entitlements (black flags) [13]. The VA and 
patient jointly developed a plan to manage health and work issues and to support the patient 
in addressing identified obstacles, with regular review. The VA also ensured that the patient’s 
GP was included in communications using the practice communications system linked to the 
patient’s medical record. This ensured that clinical issues identified as obstacles to work 
could be communicated to the GP for resolution, and that return to work plans could also be 
provided to the GP. Four healthcare practitioners were recruited to the VA role to deliver the 
service; three physiotherapists and one nurse (all vocational advice was actually delivered by 
the three physiotherapists), all completed a four day training course (developed by the study 
team and reported separately) and half day update prior to the start of the service. The VAs 
were new recruits to this role and did not provide any other services to the general practice.  
The service was “low intensity” and based on the principles of case management using a 
stepped care model to develop a goal orientated approach to remaining in or returning to 
work (Figure 1), along with the intention of getting the key players (person; healthcare; 
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workplace) onside [13]. Patients continued to be eligible for vocational advice until they 
achieved a sustained return-to-work (the patient returns to work and does not initiate contact 
with the VA for a period of at least 2 weeks) and felt able to manage their musculoskeletal 
pain in the context of their work, or until they had been absent from the workplace for a total 
of six months and qualified for Employment and Support Allowance. 
 
Outcomes 
Demographic data, health and work data were collected after GP consultation and, in the 
intervention practices, before an appointment with the VA, and at 4 and 12 months follow-up. 
Full details of the primary and secondary outcomes collected are provided in the protocol 
[12]. 
 
The primary outcome measure was number of days off work over 4 months, measured at the 
individual participant level. Work absence was identified at follow-up based on the following 
self-reported questions; “Have you taken time off work during the last 4 months (since your 
last questionnaire) because of your pain?”, “If yes, please write the number of days, weeks or 
months you were off work due to your pain in the last 4 months”. ‘Days off work’ in this 
context captures periods of self-certified absence as well as GP certified absence. For the 
purposes of this trial 1 week was classified as 5 days and 1 month as 21 days. Further 
analysis of time off work examined any self-reported time off work (binary yes/no) and GP 
certified periods over 12 months follow-up identified from the medical record. Secondary 
outcome measures included pain intensity (0-10 numerical rating scale), bothersomeness (1-5 
rating scale) [16], global assessment of change (5 point rating of general health from 
excellent to poor), self-efficacy to return-to-work (Self-efficacy to Return-to-Work 
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Questionnaire) [17], work presenteeism (Stanford Presenteeism Scale 6)[18] and self-rated 
work performance (0-10 numerical rating scale).  
 
Statistical analysis 
For the primary outcome (days off work over 4 months), the analysis was by hierarchical 
negative binomial regression adjusting for age, gender, and GP practice size (at the GP-
cluster level) [19]. The best-fitting model according to goodness-of-fit (higher log-likelihood, 
and lower Akaike’s Information Criterion (AIC) and Bayesian Information Criteria (BIC)) 
was given by a zero-inflated model; hence, the hierarchical zero-inflated negative binomial 
(ZINB) regression was used for the analysis of time off work over 4 months (primary) and 12 
months (secondary). Given the limited number of GP practices, the hierarchical model 
included individual practitioners (GPs and NPs) at the cluster-level; differences in GP 
behaviours are known to be a major influence in varying sickness certification prescribing 
practice [20]. Longitudinal mixed-models (linear- or generalised- as appropriate to numerical 
and categorical outcome data, respectively) were fitted to estimate and test for between-group 
effects across other outcome measures, adjusting for baseline covariates (age, gender and GP 
practice size). An intention-to-treat analysis was followed. The statistical analysis followed 
the plans described in the published protocol [12] and the final version of the Statistical 
Analysis Plan (SAP) agreed with the Data Monitoring Committee. 
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Sensitivity analyses  
1. Evaluation of the primary outcome measure (number of days off work by robust Poisson 
and zero-inflated models) 
2. Evaluation of the primary outcome measure (number of days off work) by a ZINB model  
with robust variance estimator [21] adjusted for (i) age, gender and practice size, and (ii) 
adjusted for age, gender, practice size plus baseline pain scores and days off work over the 
past 12 months.. 
3. Evaluation of the primary outcome measure utilising the GP practice as the unit of 
clustering rather than the individual GP/NP practitioner; including GP practice as a random 
factor intercept in the hierarchical model. 
4. A per protocol evaluation (and complier average causal effect (CACE) evaluation) 
comparing time off work for those participants in the intervention practices who engaged 
with any aspect of the vocational advice service (at least one contact with a VA) versus (i) all 
control arm participants, (ii) ‘comparable' participants in the control practices that would be 
expected to similarly adhere with treatment protocol – via an instrumental variable analysis 
(adherence / non-adherence, defined as at least one contact with the VA). 
 
Subgroup analyses 
Exploratory evaluation of the primary outcome was carried out to examine whether time off 
work appeared differed between subgroups. The three subgroup analyses agreed and 
documented in the SAP were: baseline return-to-work self-efficacy, location of pain (spinal 
pain versus pain in other areas), and duration of work absence (at least 10 days versus /less 
than 10 days). Statistical estimates were obtained through including interaction terms in the 
statistical model of treatment effect. 
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Sample size  
The sample size calculation was based on the ability to detect a between group difference of 
at least 10 days off work at 4 months, given an expected standard deviation of 25 days [22], 
80% power, and 5% two-tailed significance level. The sample size takes into account: (i) 
30% inflation through clustering of data (at practitioner-level) based on an ICC for between-
practitioner effects of 0.05 [23], variation in expected VA service referral rates between GPs 
(based on an expected coefficient of variation of 0.65) [24], and (ii) 25% inflation through 
allowance for 20% loss to follow-up at 4 months. This resulted in a required sample size of 
330 participants (165 per arm). 
 
Economic evaluation 
An incremental cost-effectiveness analysis was undertaken using mean days off work as the 
measure of outcome, to calculate the cost per sick day avoided, from a healthcare perspective. 
Patient-level healthcare costs concentrated on National Health Service (NHS) and private 
healthcare resource use for musculoskeletal pain obtained from patient questionnaires at 4 
and 12 months, and additional costs of the VA service (eTable 1, available online at 
http://links.lww.com/PAIN/A489). Hierarchical modelling was used to estimate differential 
costs and differential Quality Adjusted Life Years (QALYs) controlling for treatment arm 
and clustering [25]. Details of contact with the VAs were obtained through case report forms. 
Unit cost data relating to resource use are reported in eTable 2 (available online at 
http://links.lww.com/PAIN/A489), and a price year of 2013 was used, with costs presented in 
UK pounds (£). A cost-benefit approach was used to generate a net societal benefit and 
return-on-investment of using the VA service. Wider societal costs in relation to the VA 
intervention were assigned to self-reported work absence using the human capital approach 
by multiplying days off work during follow-up by the Standard Occupational Classification 
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(2010 edition) related respondent-specific wage rates. Discounting was not performed 
because of the 12 month follow-up period.  
 
Public and Patient Involvement and Engagement (PPIE) 
Patients with musculoskeletal pain and primary care clinicians involved in their treatment 
were involved throughout the SWAP trial, and were independent from those participating in 
the trial. PPIE representatives were involved in the development of the research question, 
were active members of the grant application with additional members involved in the trial 
steering committee and providing advice on all aspects of the design, recruitment and 
retention methods, as well as reviewing all patient facing materials.  
Results 
Recruitment 
Twenty general practices were approached with six general practices being eligible; they 
were randomised, 3 to the intervention and 3 to the control arm. Participants were recruited 
between July 2012 and January 2014; Figure 2 shows the flow of participants through the 
trial.  A total of 338 participants consented to participate in the research data collection after 
their consultation at participating practices, 158 to the intervention and 180 to the control 
arm. Follow-up was 75% (n=119) and 69% (n=109) at 4 and 12 months respectively in the 
intervention arm and 82% (n=148) and 73% (n=131) at 4 and 12 months in the control arm.  
 
Baseline characteristics 
Table 1 reports the baseline characteristics of participants, which were comparable. The mean 
age was 49.5 and 47.9 years, with 56% and 59% female in the intervention and control arms, 
respectively. The majority of participants were working full-time. Participants in the control 
arm reported that they had marginally more days of work absence in the previous 12 months. 
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At baseline, duration of symptoms, measures of pain intensity and bothersomeness were 
similar in both arms.  
 
Adherence with treatment protocol 
Of the 158 participants in the intervention practices, 120 (76%) were referred to the VA 
service (Figure 2). Of these, 97 (81%) had at least one contact with a VA. The average 
number of contacts between the VAs and patients was two with the majority of these being 
telephone contacts (89%) lasting an average of 13.3 minutes (Table 2). Exploration of health 
and work issues were frequently recorded by the VAs on case report forms, but return-to-
work planning was not commonly recorded.  
Primary outcome 
4 months 
At 4 months there was some evidence for effect in the number of days off work between arms 
with the intervention arm reporting fewer days off work mean of 9.3 (SD 21.7) days 
compared to 14.4 (SD 27.7) days in the control arm, an adjusted incidence rate ratio of 0.51 
(p=0.048). Results of the sensitivity analyses including different model estimation, non-
parametric testing, per-protocol/CACE-complier evaluation, and accounting for clustering at 
GP practice level concurred with the primary analysis in showing greater time (days) off 
work in the control arm (Table 3). The difference in days off work was largely accounted for 
by the lower number of GP certified days in the intervention arm at 8.4 (SD 21.0) days versus 
13.5 (27.5) days in the control arm (p=0.020) (Table 3). 
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12 months 
By 12 months there was no overall statistically significant difference in the cumulated 
number of days of work absence between arms. However the intervention arm reported fewer 
days off work certified by the GP at a mean of 16.4 (SD 34.2) days compared to 22.9 (SD 
50.5) days in the control arm (p=0.018). The control arm reported fewer days self-certified 
than the intervention arm at a mean of 1.5 (SD 3.3) days compared to 3.9 (SD 15.0) days 
(p=0.001) (Table 3).   
 
Exploratory subgroup analyses 
At 12 months, exploratory subgroup analyses showed that the VA service was significantly 
more successful in those with spinal pain compared to those with other musculoskeletal pain 
(Incidence Rate Ratio (IRR) 0.25 (95% Confidence Interval (CI) 0.10, 0.62) 
(pinteraction=0.003). The intervention was also significantly more successful in those who had 
work absence that exceeded 10 days at baseline compared to those with absence periods of 
less than 10 days (IRR 0.30 (95% CI 0.11, 0.83) (pinteraction=0.020) (Table 3)). Baseline level 
of self-efficacy to return-to-work had little impact on the effect of the intervention (Table 3).  
 
Secondary outcomes 
Self-reported time off work (binary yes/no) was examined as a secondary outcome. Separate 
analysis compared the proportions of participants in the two trial arms issued with a GP 
certified fit note, assessed through medical records (Table 3). Of the health-related 
(secondary) outcome measures there were few statistically significant differences between the 
intervention and control arms for measures of pain, bothersomeness, pain self-efficacy, IPQ-
R, HADS anxiety and depression and general health. Though estimated differences were 
small, the health outcomes were generally in favour of the intervention arm (Table 4). Work-
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related measures demonstrated statistically significant differences between arms, in favour of 
the intervention arm, at both 4 and 12 months in return-to-work self-efficacy and 
performance at work, and a significant difference in presenteeism at 4 months (Table 4). 
 
Economic evaluation 
The VA service resulted in greater mean benefits in terms of days off work (6.7 fewer days 
off work; adjusted difference in time off work over 12 months), at slightly higher NHS and 
healthcare costs (cost difference of £48 and £15 for NHS and healthcare perspectives 
respectively) (Table 5). From an NHS perspective, this resulted in an incremental cost-
effectiveness ratio of £7.20 per day of absence avoided.  
 
The net societal benefit of the addition of the VA service compared with best current care 
alone was £733 (£748 gain (work absenteeism) minus £15 loss (healthcare-related costs)) 
demonstrating that the intervention represents more efficient use of resources than the control 
(Table 5). The corresponding return-on-investment (ROI) from a societal perspective was £49 
(£733 divided by £15) – that is, every £1 invested in the VA service will return an estimated 
£49 ($64USD).  The inclusion of training costs and monthly mentoring brings the ROI to £25 
($30USD). 
 
The point estimate suggests that the intervention was more effective (with fewer days off 
work) and associated with higher costs than the control. eFigure 1 shows that for a 
willingness to pay of £40 per sick day avoided, the probability that the intervention is cost-
effective was slightly over 50% (available online at http://links.lww.com/PAIN/A489). 
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Discussion 
The SWAP trial demonstrated that the addition of a low intensity, early access, vocational 
advice service to best current primary care for adults consulting with musculoskeletal pain 
led to fewer days off work over 4 months, indicating some evidence for effect of the 
intervention. The intervention improved measures of work performance, presenteeism and 
self-efficacy to return-to-work. Use of the vocational advice service for musculoskeletal pain 
was associated with slightly higher costs but the cost-benefit analysis demonstrated the 
broader societal value of the VA service.  
 
Implications  
The VA service, also termed occupational advice and workplace coaching, highlighted two 
key implications relating to the study population and the intensity of intervention delivered.  
 
Timing of the intervention  
The sample included in the SWAP trial could be considered early in their “work absence 
career”; patients were eligible if they were struggling at work as well as those having a short 
period of absence (less than 6 months). Whilst the addition of the VA service led to 
significantly fewer days off work, exploratory subgroup analysis in those participants with 
<10 days absence versus ≥10 days but <6 months absent at baseline found that the 
intervention was more successful in those with the longer absence duration. Whilst early 
intervention is advocated [12] these results suggest that a VA intervention might be better 
targeted to those with more than 10 days (2 working weeks) of absence. van Duijn et al [26] 
reviewed the literature around timing of interventions for individuals on sick leave due to 
back pain, reporting the optimal window in which to intervene as 8 to 12 weeks. These 
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findings suggest the optimum time to provide support in managing health and work is likely 
to be after 10 days (approximately 2 working weeks) of absence, but this needs testing in 
future studies. 
 
Intensity of intervention delivered 
The intervention provided in the SWAP trial was low intensity with the majority of 
vocational advice delivered by telephone. This is in keeping with robust evidence that 
telephone based vocational advice can help a substantial proportion of cases to self-manage 
their health problem and may also facilitate return-to-work [27]. There is evidence that 
simple, low intensity interventions provide similar benefits to complex, multi-modal, 
interventions whilst avoiding unnecessary medicalisation. This is particularly pertinent to the 
SWAP trial where participants had short-term or no work absence and were in an ideal 
position to manage their condition with appropriate advice before their absence became long-
term. The model of stepped care evaluated in the SWAP trial is similar to that proposed by 
Burton et al [27], requiring only those with more complex needs to access costly face-to-face 
contact.  
 
Strengths and limitations 
The SWAP trial has a number of strengths. It is the first trial to evaluate a VA service 
embedded in general practice offering biopsychosocial advice to people with musculoskeletal 
pain, a leading cause of work absence. The VA service was also acceptable to patients with 
75% (253 patients) of those offered a referral accepting this offer. The SWAP trial is also the 
first to intervene so early including those who were struggling at work, with the aim of 
preventing future work absences. Whilst the stepped care vocational advice service was brief 
and mainly provided over the telephone, this method is supported by the literature showing 
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that brief vocational advice interventions are as effective as effort-intensive interventions [28] 
and there are robust data to support telephone-based interventions [27]. The Department for 
Work and Pension’s evaluation of the Fit For Work service pilots [29] also found that low 
cost interventions (equating to low intensity interventions) were more likely to be the most 
cost effective, and many of these interventions included populations with longer term absence 
indicating that there would be utility in evaluating a similar VA service in those with longer 
absence duration. A further strength of this trial concerned activities to ensure continued 
engagement with general practices.  This included a range of measures for both the 
intervention and control practices comprising; provision of an education session around 
managing health and work before the trial commenced; regular contact with the trial team 
GP; a GP “champion” in each practice who was the point of contact for the trial. In 
intervention practices, VAs actively engaged in practice life, joining breaks and staff 
meetings and providing both formal and informal feedback about the service to GPs. This 
was important given the difficulty in engaging GPs in studies of vocational advice and has 
been reported by Rannard et al (2014) [30] and the Fit for Work Pilots [29]. The finding that 
there was a difference in GP certified periods of absence could have been related to the 
visibility of the VAs in the practice, suggesting that raising the profile of available vocational 
advice services providing vocational advice may be of benefit. The qualitative analyses 
conducted alongside this trial was unable to elucidate the reasons for the decrease in the issue 
of fit notes [31] and further work is needed to identify whether the availability of a vocational 
advice service does change GP behaviour reducing the issue of fit notes or whether accessing 
vocational advice changes patients’ behaviour in asking for certified absence.  
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There are several limitations. Firstly, the association between the intervention and the 
measures of work outcomes (return-to-work self-efficacy, performance and presenteeism) 
were influenced by the adjustment of practice size due to the small number of practices, 3 
intervention and 3 control (practice size was adjusted for as it was the only stratification 
variable used in randomisation). Secondly, whilst three steps were available to the VAs in the 
delivery of the VA service, only one workplace visit was undertaken (step three), the reasons 
for which need some consideration. The VAs within the SWAP trial reported that participants 
were unwilling for them to contact their employers. Many participants were very early in 
their work absence and some were not currently absent, but struggling at work; the lack of 
employer visits may reflect the trial population and the primary care setting, where contact 
between vocational advisors and employers is uncommon, this is a finding in other similar 
studies [32]. A linked issue relates to the lack of recorded return-to-work plans on the case 
report forms of patients accessing the VA service in the intervention practices, this may be 
explained by the early nature of the participants’ work absence. Whilst many participants 
received at least one phone call from the VA many had already made their own plans to 
return-to-work and did not wish for the VA to provide them with written documentation of 
this. Thirdly, there was the potential for recall bias to be introduced when asking participants 
to recall their work absence over the past months. To examine the potential for the 
introduction of recall bias a sensitivity analysis on the number of days off work was carried 
out using the medical record data, which should eliminate recall bias. The findings of this 
sensitivity analysis again indicated that the number of days off work was reduced in the 
intervention arm. Lastly, the costs of presenteeism were not included in the economic 
evaluation because the Stanford Presenteeism Scale used could not be converted into a 
monetary value. Goetzel et al [33] reported that presenteeism accounts for between 18% and 
60% of all costs of a range of health conditions. Given that there were significant differences 
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in measures of presenteeism in favour of the intervention, it is likely that our health economic 
analyses underestimated the cost-effectiveness of the VA service. In terms of the cost 
effectiveness of the intervention and the small differences in costs and days off work, there 
remained some uncertainty around estimates. A larger sample size would be able to reduce 
this uncertainty, and provide a better cost-effectiveness interpretation. An appropriate 
threshold for this outcome needs to be determined.  
 
By way of a conservative estimate using data for back and neck pain alone rather than all 
musculoskeletal pain conditions, 31 million days are lost from work per year in the UK [34]. 
If a similar brief vocational advice service was implemented widely, it could potentially 
reduce this figure by 16%, equating to an overall societal cost-saving of about £500 million 
(216 million days lost per year, amounting to an overall saving of $6 billion for the United 
States).  
 
Future research 
Future research should build upon the intervention provided in the SWAP trial, refining the 
timing of the intervention to those who have at least 10 days work absence. Given that the 
results demonstrate benefits in patients with musculoskeletal pain, developing and testing 
vocational advice services with broader patient groups in primary care such as those with 
mental health conditions and cardiovascular disease would also be helpful.  
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Conclusions  
SWAP is the first trial to evaluate an intervention embedded in primary care providing early 
vocational advice, based on biopsychosocial principles, for patients with musculoskeletal 
pain. The trial demonstrated a reduction in days off work in favour of the vocational advice 
intervention, an increase in self-efficacy to return-to-work, reduced presenteeism and 
improved performance at work. Greater economic benefits were seen from the addition of the 
vocational advice intervention compared to best current primary care alone.  
 
 
 
Acknowledgements 
We thank the participating patients, vocational advisors, GPs, NPs and practice managers. 
We thank the independent trial steering committee and Data Monitoring Committee for their 
advice and support and the Patient and Public Involvement and Engagement research user 
group members for their involvement. The authors would like to acknowledge the support of 
the NIHR Clinical Research Network: West Midlands, the Primary Care Research 
Consortium and Keele Clinical Trials Unit for their support in delivering and hosting this 
research.  We are grateful to all the members of the wider SWAP trial team including: Helen 
Duffy (Research Institute and NHS partnership and Engagement manager), Reuben Ogollah 
(statistical support), Alicia Bratt (administration), Jackie Gray and Rhian Hughes (research 
governance and management), Julie Young (lead research nurse), and Ruth Beardmore 
(Keele CTU programme manager). Lastly, we are grateful to Staffordshire and Stoke-on-
Trent Partnership NHS Trust for clinical governance of the vocational advice service.  
 
 
AC
CE
PT
ED
Page 23 of 28 
There are no conflicts of interest.  
 
 
Protocol 
Annette Bishop, Gwenllian Wynne-Jones, Sarah A Lawton, Danielle van der Windt, Chris 
Main, Gail Sowden, A Kim Burton, Martyn Lewis, Sue Jowett, Tom Sanders, Elaine M Hay, 
Nadine E Foster and on behalf of the SWAP study team; Rationale, design and methods of 
the Study of Work and Pain (SWAP): a cluster randomised controlled trial testing the 
addition of a vocational advice service to best current primary care for patients with 
musculoskeletal pain (ISRCTN 52269669). BMC Musc Disord 2014; 15:232. 
 
Funding 
This paper presents independent research funded by the National Institute for Health 
Research (NIHR), under its Programme Grants for Applied Research funding scheme: 
“Optimal management of spinal pain and sciatica in primary care” (NIHR-RP-PG-0707-
10131). NEF and AB were funded by an NIHR Research Professorship awarded to NEF 
(NIHR-RP-011-015). NEF and EMH are NIHR Senior Investigators. GW-J is funded by an 
NIHR Post-Doctoral Fellowship (PDF-2009-02-54).  
 
 
 
 
 
 
 
AC
CE
PT
ED
Page 24 of 28 
 
References 
 
1 Confederation of British Industry Fit for Purpose: Absence and Workplace Health 
Survey; 2013 Available from: 
http://www.cbi.org.uk/media/2150120/cbipfizer_absence___workplace_health_2013.
pdf. 
2 Bevan S, Quadrello T, McGee R, Mahdon M, Vavrovsky A, Barham L. Fit For 
Work? Musculoskeletal Disorders in the European Workforce. The Work Foundation; 
2009. 
3 Zheltoukhova K. Musculoskeletal Disorders and Work: Results of a survey of 
individuals living with Musculoskeletal Disorders in six European countries; 2013.  
4 Waddell G, Burton A.K. Is work good for your health and well-being? The Stationary 
Office; 2006.  
5 eumusc.net Musculoskeletal Health in Europe Report V.5. Available from: 
http://www.eumusc.net/myUploadData/files/Musculoskeletal%20Health%20in%20Eu
rope%20Report%20v5.pdf 
6 Black C, Working for a healthier tomorrow. The Stationary Office; 2008.  
7 Waddell G, Burton A.K, Kendall N. Vocational Rehabilitation: What Works, for 
Whom, and When? The Stationary Office; 2008 
8  Hann M, Sibbald B. General practitioners’ attitudes towards patients’ health and 
work, 2010-2012, Department for Work and Pensions, Research Report No 835; 
2013. 
AC
CE
PT
ED
Page 25 of 28 
9 Aust B, Helverskov T, Nielsen M.B.D, Bjorner J.B, Rugulies R, Nielsen K, et al. The 
Danish national return-to-work program –  aims, content, and design of the process 
and effect evaluation. Scand J Work Environ Health. 2012;38(2):120–133. 
10 Nice K, Thornton P. Job Retention and Rehabilitation Pilot: Employers Management 
of Sickness Absence. Department for Work and Pensions report No 227; 2004. 
11 Bishop A, Foster N.E, Thomas E, Hay E.M. How does the self-reported clinical 
management of patients with low back pain relate to the attitudes and beliefs of health 
care practitioners? A survey of UK general practitioners and physiotherapists. Pain. 
2008; 1-2:187—95. 
12 Bishop A, Wynne-Jones G, Lawton S.A, van der Windt D, Main C, Sowden G, et al. 
Rationale, design and methods of the Study of Work and Pain (SWAP): a cluster 
randomised controlled trial testing the addition of a vocational advice service to best 
current primary care for patients with musculoskeletal pain (ISRCTN 52269669), 
BMC Musculoskelet Disord 2014; 15: 232. 
13 Kendall N.A.S, Burton A.K, Main C.J, Watson P.J, on behalf of the Flags Think-
Tank: Tackling Musculoskeletal Problems: a Guide for the Clinic and Workplace – 
Identifying Obstacles Using the Psychosocial Flags Framework. The Stationary 
Office; 2009. 
14 Kendall NA, Linton SJ, Main CJ. Guide to Assessing Psychosocial Yellow Flags 
in Acute Low Back Pain: Risk Factors for Long-Term Disability and Work Loss. 
Wellington, New Zealand: Accident Rehabilitation and Compensation Insurance 
Corporation of New Zealand and the National Health Committee; 1997. 
15 Shaw, W.S., van der Windt, D. A, Main, C.J., Loisel, P., Linton, S.J., Decade of 
the Flags Working Group. 2008. Early patient screening and intervention to 
address individual level Occupational Factors (“Blue Flags”) in Back Disability. J 
AC
CE
PT
ED
Page 26 of 28 
Occ Rehab. Published online 12/12/08. Springer Science & Business Media. LLC 
2008. 
16 Dunn K.M, Croft P.R, Classification of low back pain in primary care: Using 
“Bothersomeness” to Identify the Most Severe Cases. Spine. 2005; 30:1887—1892. 
17 Shaw W.S, Reme S.E, Linton S.J, Huang Y.H, Pransky G. 3rd place, PREMUS best 
paper competition: development of the return-to-work self-efficacy (RTWSE-19) 
questionnaire--psychometric properties and predictive validity. Scand J Work Environ 
Health. 2011; 37:109—19. 
18 Koopman C, Pelletier K.R, Murray J.F, Sharda C.E, Berger M.L, Turpin R.S. et al. 
Stanford Presenteeism Scale: Health Status and Employee Productivity. J Occup 
Environ Med. 2002; 44:14—20. 
19 Fournier D.A, Skaug H.J, Ancheta J, Ianelli J, Magnusson A, Maunder M. et al. 
Model Builder: using automatic differentiation for statistical inference of highly 
parameterized complex nonlinear models. Optim Method Soft. 2011; 27: 233—249. 
20 Watson P.J, Bowey J, Purcell-Jones G, Gales T. General practitioner sickness absence 
certification for low back pain is not directly associated with beliefs about back pain. 
Eur J Pain. 2008; 12:314—320. 
21 Hilbe, J. M. sg102: Zero-truncated Poisson and negative binomial regression. Stata 
Technical Bulletin 47: 37–40. Reprinted in Stata Technical Bulletin Reprints 1999; 
8:233—236. College Station, TX: Stata Press, 1999. 
22 Weidenhammer W, Linde K, Streng A, Hoppe A, Melchart D. Acupuncture for 
chronic low back pain in routine care. Clin J Pain. 2007; 23:128—135. 
23 Lewis M, Morley S, van der Windt DA, Hay E, Jellema P, Dziedzic K. et al. 
Measuring practitioner/therapist effects in randomised trials of low back pain and 
neck pain interventions in primary care settings. Eur J Pain. 2010; 14:1033—1039. 
AC
CE
PT
ED
Page 27 of 28 
24 Eldridge S.M, Deborah D, Kerry S. Sample size for cluster randomized trials: effect 
of coefficient of variation of cluster size and analysis method. Int J Epidemiol. 2006; 
35:1292—1300. 
25 Gomes M, Ng E, Grieve R, Nixon R, Carpenter J, Thomson S. Developing 
appropriate methods for cost-effectiveness analysis of cluster randomised trials. 
Medical Decision Making. 2012; 32: 350-361. 
26 van Duijn, M, Eijkemans M.J, Koes B.W, Koopmanschap M.A, Burton A.K, Burdorf 
A. The effects of timing on the cost-effectiveness of interventions for workers on sick 
leave due to low back pain. Occup Environ Med. 2010; 67:744—750. 
27 Burton K, Kendall N, McClusky S, Dibben P. Telephonic support to facilitate return 
to work: what works, how and when? Department for Work and Pensions. Report No 
853, 2013. 
28 Palmer K.T, Harris E.C, Linaker C, Barker M, Lawrence W, Cooper C, Coggon D. 
Effectiveness of community and workplace based interventions to manage 
musculoskeletal-related sickness absence and job loss: a systematic review. 
Rheumatology. 2012; 51:230—242. 
29 Hillage J, Williams M, Marvell R, Shiels C, Gabbay M, Weston K, Humphreys I. 
Evaluation of the 2010-13 Fit for Work Service pilots: final report. Department for 
Work and Pensions, Report No 896, 2015. 
30 Rannard A, Gabbay M, Sen D, Riley R, Britt D. Feasibility trial of GP and case-
managed support for workplace sickness absence. Prim Health Care Res Dev. 2014; 
15:252—261. 
31 Sanders T, Wynne-Jones G, Artus M, Ong BN, Foster NE, Acceptability of a 
vocational advice service for patients consulting in primary care with musculoskeletal 
pain: A qualitative exploration of the experiences of general practitioners, vocational 
advisors and patients, Scandinavian Journal of Public Health, 2017, In Press 
AC
CE
PT
ED
Page 28 of 28 
32 Coole C, Birks E, Watson P.J, Drummond A. Communicating with Employers: 
Experiences of Occupational Therapists treating people with musculoskeletal 
conditions. J Occup Rehabil. 2014; 24:585—595. 
33 Goetzel R.Z, Long S.R, Ozminkowski R.J, Hawkins K, Wang S, Lynch W. Health, 
absence, disability and presenteeism cost estimates of certain physical and mental 
health conditions affecting U.S employers. J Occup Environ Med. 2004; 46:398—
412. 
34  Office for National Statistics, Full Report: Sickness Absence in the Labour Market 
February 2014, 
http://www.ons.gov.uk/employmentandlabourmarket/peopleinwork/labourproductivit
y/articles/sicknessabsenceinthelabourmarket/2014-02-25 
 
 
Figure legends 
Figure 1: Model of stepped care provided by the vocational advisor (VA) 
Figure 2: CONSORT Flow diagram 
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Table 1: Baseline characteristics of trial participants by treatment group 
 
  Intervention arm 
 
Control arm 
 n=158* n=180* 
Age, mean (SD) 49.5 (9.6) 47.9 (10.7) 
Gender, n (%)   
   Females 89 (56%) 106 (59%) 
   Males 69 (44%) 74 (41%) 
Duration of symptoms, n (%)   
   < 2 weeks 19 (12%) 28 (16%) 
   2-6 weeks 31 (20%) 49 (28%) 
   6-12 weeks 28 (18%) 29 (16%) 
   3-6 months 28 (18%) 31 (18%) 
   7-12 months 16 (10%) 15 (8%) 
   > 12 months 35 (22%) 25 (14%) 
Time since pain free month, n (%)   
   < 3 months 53 (34%) 58 (34%) 
   4-6 months 12 (8%) 29 (17%) 
   7-12 months 24 (15%) 22 (13%) 
   1-3 years 21 (13%) 32 (18%) 
   > 3 years 46 (30%) 32 (18%) 
NRS-Pain average last 2 weeksa, mean (SD) 6.9 (2.0) 7.0 (1.7) 
NRS-Pain least pain last 2 weeksa, mean (SD) 4.2 (2.4) 3.8 (2.5) 
NRS-Pain intensity at presenta, mean (SD) 5.6 (2.5) 5.4 (2.6) 
NRS-Pain score summarya, mean (SD) 5.5 (1.9) 5.4 (1.8) 
Bothersomeness, n (%)   
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   Not at all 0 (0%) 0 (0%) 
   Slightly 3 (2%) 3 (2%) 
   Moderately 41 (26%) 42 (23%) 
   Very much 66 (42%) 85 (47%) 
   Extremely 48 (30%) 50 (28%) 
General health, n (%)   
   Excellent  13 (8%) 13 (7%) 
   Very good 45 (28%) 62 (34%) 
   Good 61 (39%) 66 (37%) 
   Fair 31 (20%) 29 (16%) 
   Poor 8 (5%) 10 (6%) 
HADS anxietyb, mean (SD) 8.0 (4.4) 7.8 (4.1) 
HADS depressionc, mean (SD) 6.8 (4.3) 7.0 (4.2) 
Working full-time, n (%) 111 (71%) 122 (68%) 
Time off work due to pain (past 12 months), n (%) 87 (55%) 113 (63%) 
Days off work (past 12 months), mean (range) 15.0 (0-147) 17.8 (0-252) 
Has self-certified, n (%) 43 (27%) 57 (32%) 
   Percent of days off through self-certification,  31% 29% 
Has been issued a sick note / fit note, n (%) 60 (38%) 82 (46%) 
   Percent of days off through sick-certification  69% 71% 
Satisfaction with workd, mean (SD) 6.4 (2.5) 6.4 (2.4) 
Performance at worke, mean (SD) 6.1 (2.6) 6.4 (2.9) 
Stanford Presenteeism Scalef, mean (SD) 18.1 (5.4) 18.0 (5.4) 
Self-efficacy – Return to Workg, mean (SD) 65.9 (27.6) 65.3 (28.8) 
Current work situation, n (%)   
   Doing usual job 97 (61%) 97 (55%) 
   On paid annual leave / holiday 3 (2%) 4 (2%) 
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   Working fewer hours 12 (8%) 5 (3%) 
   Doing lighter duties 7 (4%) 9 (5%) 
   On paid sick leave 35 (22%) 51 (29%) 
   On unpaid leave 4 (3%) 11 (6%) 
Difficulty managing at work, n (%)   
   Not at all 2 (1%) 5 (3%) 
   Slightly 23 (15%) 34 (19%) 
   Moderately 52 (34%) 61 (34%) 
   Very much 45 (29%) 35 (20%) 
   Extremely 32 (21%) 44 (25%) 
NS-SEC   
1 16 (8.9%) 2 (1.2%) 
2 35 (19.4%) 40 (26.0%) 
3 36 (20.0%) 28 (18.2%) 
4 4 (2.2%) 13 (8.4%) 
5 9 (5.0%) 12 (7.8%) 
6 41 (22.8%) 32 (20.8%) 
7 39 (21.7%) 27 (17.5%) 
Work is physically demanding 110 (71%) 119 (66%) 
Size of organisation >250 staff 44 (29%) 65 (37%) 
 
a
 NRS-Pain scales are 0-10 where 0=no pain, 10=pain as bad as can be;  
b
 Pain self-efficacy scale 0-60 where 0=no confidence, 60=highest confidence;  
c HADS anxiety/depression subscales 0-21 scales where 0=no anxiety/depression, 21=highest anxiety/depression 
(clinical cut-offs are given as ≥8 ‘possible cases’ and ≥11 ‘probable cases’);  
d
 Satisfaction with work 0-10 NRS scale where 0= not at all satisfied, 10=completely satisfied;  
e
 Performance at work 0-10 NRS scale where 0=not at all affected, 10=pain is so bad that unable to do job. 
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f Stanford Presenteeism (6-36 integer scale) where 6=lowest level of presenteeism, 36 highest level of 
presenteeism; 
g Self-efficacy Return-to-Work (0-114 scale) where 0=not at all confident, 114=totally confident. 
* Not all figures add to the corresponding group totals due to some missing baseline data. 
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Table 2: Summary of Vocational Advice service delivered 
 
  
Participants referred to VA service, n (% of intervention group) 120 (76%) 
At least one participant contact with the VA 97 (81%) 
Number of contact attempts per participant, median (IQR) 4 (2 – 5) 
Number of actual contacts per participant, median (IQR) 2 (1 – 3) 
  
Contacts  
Total number of participant contact attempts 489 
     Number of actual participant contacts 226 (37%) 
          via telephonea 202 (89%) 
          via face-to-face contactb 17 (8%) 
          other (e.g. letter)  7 (3%) 
† Duration of telephone call, median (IQR) 13.3 (10 – 20) 
‡ Duration of face-to-face visit, median (IQR) 60.0 (35 – 63.5) 
  
     Content of vocational advice service  
     Exploration of health issues 197 (87%) 
     Exploration of work situation 176 (78%) 
     Oral information provided 138 (61%) 
     Assessment of obstacles/’flags’ c 115 (51%) 
     Written information provided 20 (9%) 
     Explored work situation 11 (5%) 
     Developed Return-To-Work plan 7 (3%) 
  
Number of stakeholder contacts 125 
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Figures are frequency count (percent) unless otherwise specified.  
a All 17 face-to-face contacts were with 17 different participants (one of these face-to-face contacts was carried 
out in the participant’s workplace). 
b Stakeholder contacts were predominantly discharge letters to GPs.  
c The Flags framework is a system for identifying obstacles to working. 
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Table 3: Evaluation of the primary outcome measure (days off work) and key secondary outcomes relating to time off work over 4 and 12 months follow up 
 
 4 months 12 months 
 Intervention 
arm 
Control  
arm 
IRRa / OR 
(95% CI) 
P-value Intervention 
arm 
Control  
arm 
IRRa / OR 
(95% CI) 
P-value 
 n=119 n=148   n=101 n=122   
         
Days off workb, mean (SD) 9.29 (21.7) 14.4 (27.7) 0.51 (0.26, 0.99) 0.048 20.3 (40.6) 24.3 (50.7) 0.65 (0.34, 1.25) 0.198 
     - via self-certification    0.85 (4.11) 0.95 (3.81) 1.14 (0.50, 2.56) 0.759 3.86 (15.0) 1.47 (3.27) 2.97 (1.60, 5.52) 0.001 
     - via Fit note(s) 8.43 (21.0) 13.5 (27.5) 0.66 (0.46, 0.94) 0.020 16.4 (34.2) 22.9 (50.5) 0.61 (0.41, 0.92) 0.018 
         
Subgroup analysisc         
Self-efficacy return-to-workd   1.01 (0.87, 1.17) 0.877   1.08 (0.93, 1.26) 0.312 
Spinal pain vs. pain in other arease   0.69 (0.27, 1.77) 0.440   0.25 (0.10, 0.62) 0.003 
Days-off (prior 12 months)f   0.93 (0.78, 1.11) 0.420   0.83 (0.67, 1.03) 0.092 
     - exceeding 10 daysg   0.42 (0.17, 1.01) 0.053   0.30 (0.11, 0.83) 0.020 
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Secondary outcomes      
Any reported time off workh, n 
(%) 
40 (33.6%) 56 (37.8%) 0.64 (0.33, 1.23) 0.182 52 (50.5%) 64 (51.6%) 0.69 (0.34, 1.38) 0.288 
         
Medical record review        
Fit note issuedi, n (%) 51 (32.3%) 70 (38.9%) 0.53 (0.25, 1.13) 0.103 52 (50.5%) 64 (51.6%) 0.55 (0.29, 1.04) 0.065 
Number of fit notes issued, 
mean (SD) 
0.68 (1.29) 0.94 (1.60) 0.60 (0.35, 1.01) 0.053 1.11 (1.92) 1.51 (2.57) 0.63 (0.37, 1.05) 0.073 
         
 
a
 Incidence rate ratio (IRR) was the effect of interest (except for self-report time off work (yes/no) and whether a fit note was issued to the participant (yes/no) where the 
effect of interest was odds ratio (OR)).  
b
 Sensitivity analysis of primary outcome (days off work over 4 months, 12 months follow up): (1i) Zero-inflated negative binomial (ZINB) regression with robust variance 
estimator adjusted for age, gender and practice size [IRR=0.56 (p=0.009) at 4 months, IRR=0.65 (p=0.107) at 12 months]; (1ii) ZINB adjusted for age, gender, practice size 
plus baseline pain scores and days off over the past 12 months [IRR=0.57 (p=0.004) at 4 months, IRR=0.79 (p=0.391) at 12 months]; (2) Nonparametric (Mann-Whitney U 
test) comparison of mean ranks (days off work aggregated at cluster (GP-level)) [p=0.343 (4 months), p=0.175 (12 months)]; (3i) Per protocol analysis [IRR=0.52 (p=0.005) 
at 4 months, IRR=0.55 (p=0.036) at 12 months]; (3ii) Complier average causal effect (CACE) analysis based on two-stage least squares instrumental variable with robust 
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variance (compliers defined as having at least one contact with the VA (n=97)) [p=0.051 (4 months), p=0.147 (12 months)]. (4) GP practice as random factor (cluster 
variable) [p=0.019 (4 months), p=0.198 (12 months)]. 
c
 Subgroup analyses as pre-specified in the published study protocol:  
d
 Units denote 10-point increments on the self-efficacy scale;  
e
 Days off over 4 months follow up (i) Control group, no spine pain (n=55, mean=10.4, SD 24.7); (ii) Control group, spine pain (n=93, mean=16.8, SD 29.2); (iii) 
Intervention group, no spine pain (n=42, mean=15.1, SD 26.0); (iv) Intervention group, spine pain (n=77, mean=6.1, SD 18.3); days off over 12 months follow up (i) Control 
group, no spine pain (n=46, mean=11.8, SD 22.1); (ii) Control group, spine pain (n=76, mean=32.0, SD 60.8); (iii) Intervention group, no spine pain (n=34, mean=32.0, SD 
54.0); (iv) Intervention group, spine pain (n=67, mean=14.3, SD 30.6).  
f
 Units denote 20-day increments (i.e. about 1 month) on the scale of days off work (g additional subgroup analysis requested by TSC).  
h
 Time off work (yes/no) – frequency counts (percent) are for participants who reported having had time off work.  
i Agreement between self-reported time off work (yes/no) and medical record review of issuing of fit note(s) (yes/no) was 70% (187/267) over 4 months and 62% (146/234) 
over 12 months. 
Days off work, QL-QU (90th percentile; max) mean (range) intervention group 4 months: 0-5 (40; 84) via self-certification 0-0 (2; 40) via Fit note 0-0 (40; 84). Intervention 
group 12 months: 0-15 (80; 210), via self-certification 0-0.3 (8; 126), via Fit note 0-10 (63; 188). Control group 4 months 0-10 (90; 84), via self-certification 0-0 (3; 42), via 
Fit note 0-10 (63; 188). Control group 12 months 0-3 (75; 252), via self-certification 0-1 (5-19), via Fit note 0-25 (75; 252). 
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Table 4: Evaluation of secondary outcome measures over 4 and 12 months follow up.  
 
 4 months 12 months 
 Intervention 
arm 
Control arm MD a /OR b 
(95% CI) 
P-value Intervention 
arm 
Control arm MD a /OR b 
(95% CI) 
P-value 
Pain-related         
NRS-Pain average last 2 weeks, mean 
(SD) 
4.3 (2.8) 5.1 (2.8) 
-0.78 a 
(-1.61, 0.04) 
0.063 3.6 (3.0) 4.4 (2.4) 
-0.76 a 
(-1.82, 0.30) 
0.159 
NRS-Pain least pain last 2 weeks, mean 
(SD) 
2.9 (2.5) 3.1 (2.5) 
-0.20 a 
(-1.05, 0.64) 
0.636 2.3 (2.6) 2.4 (2.3) 
-0.09 a 
(-1.03, 0.85) 
0.854 
NRS-Pain intensity at present, mean 
(SD) 
3.3 (2.7) 4.0 (2.9) 
-0.63 a 
(-1.58, 0.32) 
0.191 2.8 (3.0) 3.6 (2.6) 
-0.86 a 
(-1.96, 0.23) 
0.122 
NRS-Pain score summary, mean (SD) 3.5 (2.5) 4.1 (2.5) 
-0.56 a 
a
 
(-1.37, 0.24) 
0.172 2.9 (2.7) 3.5 (2.3) 
-0.59 a 
(-1.56, 0.38) 
0.231 
Global change, n (%)         
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   Completely recovered 6 (6) 5 (4) 0.87 b 0.753 11 (13) 8 (7) 0.96 b 0.939 
   Much improved 18 (18) 33 (27) (0.35, 2.13)  25 (30) 38 (35) (0.32, 2.85)  
   Somewhat improved 27 (27) 31 (26)   12 (15) 25 (23)   
   Same 28 (28) 29 (24)   16 (20) 26 (24)   
   Somewhat worse 15 (15) 18 (15)   10 (12) 10 (9)   
   Much worse 5 (5) 5 (4)   8 (10) 2 (2)   
Bothersomeness, n (%)   0.82 b 0.635   0.44 b 0.052 
   Not at all 2 (2) 3 (2) (0.36, 1.87)  7 (7) 4 (3) (0.20, 1.01)  
   Slightly 22 (19) 35 (25)   24 (23) 26 (21)   
   Moderately 44 (38) 47 (33)   34 (32) 51 (41)   
   Very much 30 (26) 39 (27)   27 (26) 38 (30)   
   Extremely 17 (15) 18 (13)   13 (12) 6 (5)   
         
Psychological variables & general 
health 
        
Pain self-efficacy scale, mean (SD) 41.0 (15.1) 38.0 (14.6) 3.00 a 
(-1.52, 7.53) 
0.193 44.7 (14.8) 42.9 (12.2) 1.84 a 
(-3.14, 6.82) 
0.470 AC
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Illness Perceptions (IPQ-R Short form), 
n (%) 
- -   - -   
   Identity, median (IQR) 5 (3, 5) 5 (4, 5) 
-0.24 a 
(-0.62, 0.14) 
0.213 5 (3, 5) 4 (3, 5) 
-0.10 a 
(-0.57, 0.38) 
0.681 
   Timeline, n (%) 71 (68.9) 77 (61.1) 0.79 b 
(0.21, 2.97) 
0.732 44 (53.0) 66 (60.0) 0.19 b 
(0.04, 0.91) 
0.037 
   Consequences, n (%) 58 (56.3) 64 (50.8) 0.40 b 
(0.09, 1.83) 
0.239 34 (40.5) 44 (40.0) 0.36 b 
(0.05, 2.52) 
0.304 
   Personal control, n (%) 49 (48.5) 56 (45.9) 3.41 b 
(1.08, 10.7) 
0.036 40 (48.8) 55 (50.5) 1.65 b 
(0.43, 6.32) 
0.464 
   Treatment control, n (%) 70 (69.3) 76 (62.3) 1.27 b 
(0.46, 3.49) 
0.639 45 (54.2) 63 (57.3) 0.97 b 
(0.32, 2.90) 
0.952 
   Illness coherence, n (%) 23 (22.8) 29 (23.8) 0.72 b 
(0.20, 2.57) 
0.618 12 (14.5) 24 (21.8) 0.11 b 
(0.01, 0.81) 
0.031 
   Timeline cyclical, n (%) 50 (49.5) 60 (49.2) 1.77 b 
(0.58, 5.39) 
0.315 30 (36.1) 67 (60.9) 0.17 b 
(0.04, 0.75) 
0.019 AC
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   Emotional representation, n (%) 65 (64.4) 86 (70.5) 0.30 b 
(0.07, 1.22) 
0.093 47 (56.6) 59 (54.1) 0.54 b 
(0.11, 2.64) 
0.445 
HADS anxiety, mean (SD) 6.6 (4.7) 7.9 (4.3) 
-1.31 a 
(-2.63, 0.00) 
0.050 6.6 (4.1) 7.1 (4.0) 
-0.52 a 
(-1.92, 0.87) 
0.461 
HADS depression, mean (SD) 5.7 (4.2) 6.1 (3.9) 
-0.37 a 
(-1.64, 0.91) 
0.572 4.7 (3.9) 5.2 (3.8) 
-0.47 a 
(-1.81, 0.87) 
0.489 
General health, n (%)   1.01 b 0.985   0.39 b 0.116 
   Excellent  8 (8) 8 (6) (0.33, 3.07)  4 (5) 4 (4) (0.12, 1.26)  
   Very good 29 (29) 30 (24)   27 (34) 36 (33)   
   Good 32 (32) 54 (43)   29 (36) 46 (42)   
   Fair 26 (26) 30 (24)   17 (21) 21 (19)   
   Poor 6 (6) 4 (3)   3 (4) 3 (3)   
         
Work-related         
Stanford Presenteeism Scale, mean (SD) 21.3 (5.4) 19.1 (5.9) 2.23 a 
(0.35, 4.10) 
0.020 22.0 (5.6) 20.1 (5.7) 1.89 a 
(-0.24, 4.03) 
0.082 AC
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Self-efficacy – Return to Work, mean 
(SD) 
81.5 (26.8) 70.1 (27.2) 11.4 a 
(2.97, 19.8) 
0.008 82.6 (27.1) 73.7 (24.1) 8.91 a 
(0.04, 17.8) 
0.049 
Satisfaction with work, mean (SD) 6.4 (2.8) 6.0 (2.3) 0.38 a 
(-0.45, 1.20) 
0.369 6.2 (2.6) 6.1 (2.3) 0.06 a 
(-0.83, 0.95) 
0.894 
Performance at work, mean (SD) 4.1 (2.8) 5.1 (3.0) 
-1.05a 
(-1.96,-0.14) 
0.023 3.4 (3.1) 4.6 (2.9) 
-1.11 a 
(-2.12,-0.09) 
0.032 
 
Descriptive summaries are marginal mean (standard deviation) or frequency count (percent) as appropriate to the type of data being summarised (numerical or categorical, 
respectively).  
a
 MD = Mean Difference (by linear mixed model) / b OR = Odds Ratio (by binary/ordinal logit mixed model) adjusted for age, gender and practice size. Attitudes and beliefs 
(patients) re: work and health will be reported elsewhere to allow the measure to be developed. The content of the GP/NP consultation and questions regarding treatment 
satisfaction will also be reported separately.  
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Table 5: Results of the economic evaluation. Values are means (standard deviations) unless stated 
otherwise 
 
 
 Intervention arm 
n = 109 
Control arm 
n = 131 
Cost analysis    
Mean (SD) NHS cost (£) 
 
528.34 (1110.49) 480.29 (938.77) 
Adjusted mean difference (95% CI) [p-value]b 48.04 (-209.58 to 305.68) [0.715] 
Mean (SD) Healthcare cost (£) 
 
568.10 (1127.39) 553.32 (976.58) 
Adjusted mean difference (95% CI) [p-value]b 14.78*  (-249.76 to  279.33) [0.913] 
Total indirect costs (Benefit) (£) 1636.69  
(3671.02) 
2257.56  
(5233.29) 
Adjusted mean difference (95% CI) [p-value]b -748** (-2278.45 to  781.44) 
Effectiveness analysis (Work-related outcomes)    
Mean (SD) Days off work   
  
20.26 (40.63) 24.34 (50.67) 
Adjusted days off work   
Mean difference (95% CI’s) [p-value]b 
 
-6.67 (-23.55 to 10.20) [0.438] 
Cost effectiveness and cost-benefit analyses    
ICER NHS perspective  -£7.2 per sick day avoided 
ICER Health care perspective   -£2.2 per sick day avoided 
Net societal benefit  £733 (£748**-£15*) 
Return on Investment (per £1 invested)  £49 (£733/£15*) 
CEA – based on the net monetary benefit (NMB) *; ICER – Incremental cost-effectiveness ratio
. 
b Incremental days off work estimated controlling for group and GP Clustering using a GLM regression model, assuming a Gaussian Variance function, an identity Link 
Function, and clustered standard errors;  
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• Initial assessment of beliefs about work and health and obstacles to remaining 
in/returning to work. 
• Discuss date for return to work. 
 
Step 1: Telephone 
contact with the 
VA 
• Assessment of obstacles to work. 
• Develop strategies tackle these. 
• Develop return to work plan. 
 
Step 2: Face to 
face meeting with 
the VA 
• Targeted advice 
• Contact workplace and other 
services (as required). 
• Set new date for RTW 
 
Step 3: Further 
face to face 
meetings with the 
VA 
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* 7 participant withdrawals between baseline and 4 months follow up: 4 did not wish to take part (2 in the Intervention group 
and 2 in the Control group); 3 had moved away (2 in the Intervention group and 1 in the Control group).  
Non participant: 
To trial: 178 patients (53%) 
To trial and medical record 
review: 182 (54%) 
Randomised to control: 3 practices 
Randomised: 6 practices  
Average cluster size 10,000 registered patients  
Randomised to intervention: 3 
practices 
Mailed patients: 336 patients Mailed patients: 424 patients 
Non participant: 
To trial: 244 patients (58%) 
To trial and medical record 
review: 253 (60%) 
Post consultation participant: 
180 (42%) responders 
Post consultation participant: 
158 (47%) responders 
4 months:  
119 (75%) responders 
35 (22%) non-responders 
4 (3%) patient withdrawals* 
12 months:  
109 (69%) responders 
44 (28%) non-responders 
5 (3%) cumulated withdrawals** 
 
4 months:  
148 (82%) responders 
29 (16%) non-responders 
3 (2%) patient withdrawals* 
12 months:  
131 (73%) responders 
42 (23%) non-responders 
7 (4%) cumulated withdrawals** 
 
Referred to the VA 
service: 
133 (75%) 
Not referred to the VA 
service 
45 (25%) 
Referred to the VA 
service: 
120 (76%) 
Not referred to the VA 
service: 
38 (24%) 
Number of VA Service referrals 
without SWAP study pack issue: 
6 (2%) AC
CE
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** 5 participant withdrawals between 4 months and 12 months follow up: 1 did not wish to take part (Intervention group); 2 
had moved away (Control group); 1 returned blank questionnaire (Control group); 1 withdrawal reason not known (Control 
group).  
